CIK 0002070849 · Non-accelerated filer<br>Emerging growth company
BillionToOne, Inc.
Sign in to watch- Ticker
- BLLN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811082020
- Phone
- 650-460-2551
- Business address
- 1035 O'BRIEN DRIVE, MENLO PARK, CA
- 4 Planned sale SVP of Laboratory Operations sold 1,416 shares at $97.54 ($138,117)
- 4 Planned sale Chief Technology Officer sold 20,000 shares at an average $98.77 ($1,975,400)
- 4 Planned sale See Remarks sold 20,000 shares at an average $99.99 ($1,999,880)
- 4 Conversion Chairman and CEO acquired 20,000 shares (conversion)
- 4 Conversion Chief Technology Officer acquired 20,000 shares (conversion)
- 4 Other disposition Director disposed of 484,442 shares (other)
- 4 Planned sale Chief Technology Officer sold 10,000 shares at $100.00 ($1,000,000)
- 4 Planned sale SVP of Laboratory Operations sold 1,417 shares at $100.00 ($141,700)
- 4 Planned sale SVP of Laboratory Operations sold 1,417 shares at $92.86 ($131,583)
- 4 Planned sale Chief Technology Officer sold 10,000 shares at $92.86 ($928,600)
- 4 Planned sale Chairman and CEO sold 15,539 shares at $150.03 ($2,331,352)
- 4 Planned sale Chairman and CEO sold 45,000 shares at an average $137.07 ($6,167,960)
- 4 Planned sale Chief Product Officer sold 4,000 shares at $140.21 ($560,840)
- 4 Planned sale See Remarks sold 14,199 shares at an average $128.29 ($1,821,628)
- 4 Planned sale SVP of Laboratory Operations sold 4,251 shares at $125.46 ($533,330)
- 4 Planned sale Chief Technology Officer sold 20,000 shares at an average $124.88 ($2,497,698)
- 4 Planned sale Chairman and CEO sold 12,500 shares at an average $126.10 ($1,576,276)
- 4 Planned sale Chief Product Officer sold 8,000 shares at $125.00 ($1,000,000)
- 4 Planned sale Chairman and CEO sold 38,750 shares at an average $122.05 ($4,729,379)
- 4 Planned sale See Remarks sold 801 shares at $124.91 ($100,056)
Page 2 of 5 · 87 filings